Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based Advisor operating in the Health Care space. If you think a Advisor is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Richard Ferrans
Advisor, Chief Medical Informatics Officer of Medigram
As advisor at Medigram, Dr. Richard Ferrans acts in a CMIO capacity to help redesign clinical operations for health system customers. This is to optimize physician performance and health system finances to manage populations under risk bearing contracts. Dr. Ferrans focuses on solving clinical, technical, and cultural barriers to change. Dr. Ferrans is a former ACO CEO, MA and CI Network CMO, and Health System CIO and CMIO.
Follow Richard Ferrans:
About Medigram: Medigram provides instant insight to save lives and make hospitals millions on iOS, Android, & the web. It is a full stack system.
David Rust
Co-Founder & Advisor of Lively
David is a seasoned operator who helped scale Lyft from 25 to 1,600 employees and an $11B+ valuation. He launched Lyft’s first markets across the US and translated these learnings into the company’s national expansion playbook. David then went on to build and lead Lyft’s internal strategy team, reporting to Lyft’s COO. This team was responsible for leading high-priority strategic initiatives, from Lyft’s partnership with General Motors to its first self-driving car implementations. Prior to Lyft, David led market expansion and local marketing for one of the early pioneers in the car sharing industry, Wheelz, which was acquired by RelayRides (not Turo). David graduated from Stanford University with a degree in Environmental Engineering and was named as a member of the Forbes 30 Under 30 class of 2017.
Follow David Rust:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
Tom Hildebrandt
Scientific Advisory Board of Noom
Tom Hildebrandt is Advisor at Noom.
Follow Tom Hildebrandt:
About : Noom is a psychology-based digital health platform used to provide intelligent nutrition and exercise coaching.
Laurie Tennant
Principal, People Advisory of Norwest Venture Partners
Follow Laurie Tennant:
About Norwest Venture Partners: Norwest is a global venture capital and growth equity investment firm that specializes in venture and growth equity companies.
Mark Perry
Strategic Advisor of New Enterprise Associates
Follow Mark Perry:
About : New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Beverley Kane
Member of the Medical Advisory Board of Healthline Media
Kane is a medical informatics specialist who received her medical degree from the University of California San Francisco. She completed a Family Practice Residency at San Francisco General Hospital, where she co-created the Department of Medicine’s Alternative Therapies Unit, one of the first programs of its kind in a major US medical center. She became board certified in Family Practice and completed fellowships in Obstetrics and Gynecology and in Sports Medicine. She worked in the private practice of sports medicine in San Francisco, where she was medical director of the San Francisco Marathon; in multiple risk factor intervention at the Stanford Center for Research in Disease Prevention; as the physician at Apple Computer for nearly 10 years; as chief medical officer of Philips Medical Systems’ EMR division; and as the consumer-professional portals liaison at WebMD. Passionate about the provider-patient relationship, Kane chaired the American Medical Informatics Association’s Internet Working Group and co-wrote AMIA’s Guidelines for the Clinical Use of Electronic Mail With Patients. She now consults at Healthline and teaches, with her equine partners, Medicine and Horses, a doctor-patient communications course at Stanford Medical School.
Follow Beverley Kane:
About : Healthline Media is the 2nd largest and fastest growing consumer health publisher in the world, reaching 85 million people a month.
David Bills
Senior Advisor of Incentrum Group
David G. Bills serves as a Senior Advisor to Incentrum Group. He was previously Senior Vice President – Corporate Strategy at DuPont, with responsibility for companywide strategy, business planning, and mergers and acquisitions. He joined DuPont on May 1, 2001, as vice president of DuPont Corporate Plans. From 2003 to 2004 he was vice president and general manager of DuPont Displays. In 2004, he was named vice president and general manager for DuPont Fluoroproducts. In October 2006 he was named senior vice president and chief marketing and sales officer for DuPont. He was named to his current position in November 2009. Prior to joining DuPont, Mr. Bills was a partner in the Chicago office of McKinsey & Company, providing strategic guidance and consultation to industrial and technology companies. At McKinsey, Mr. Bills served as co-leader of the firm’s worldwide Growth Strategy Practice and was a member of the Corporate Finance and Industrial Marketing Practices. Mr. Bills received his bachelor of science degree in Chemical Engineering from the University of Wisconsin in 1983 and his master of business administration from Harvard Business School in 1989. Mr. Bills currently serves on the board of directors of Modine Manufacturing Company. He formerly served on the board of trustees of the Delaware Art Museum, and on the Advisory Board of the Lerner College of Business at the University of Delaware.
Follow David Bills:
About : Incentrum Group is a merchant bank focused on the Healthcare, Life/Material Science, and Technology Industries.
Peter Boling
Tech Evangelist (Advisor) of Karuna Health
Experienced team leader, rubyist, systems architect, technical co-founder, CTO, advisor, polyglot, humanitarian, advocate
Follow Peter Boling:
About Karuna Health: Karuna connects patients with healthcare guides through streamlined communication and automation.
Stuart Auerbach
Senior Advisor of Ampersand Capital Partners
Stuart Auerbach, a founding member and former director and treasurer of the TBM 700 Owners and Pilots Association, earned his private pilot certificate more than 30 years ago. Today, Stuart is a CFI and ATP, and holds single-and multiengine land and sea, turbojet, and rotorcraft ratings. He is a member of EAA’s President’s Circle and President’s Council. Professionally, Stuart serves as a general partner at Ampersand Capital Partners. He holds a bachelor’s degree in engineering from Columbia University and a master’s in business administration from Harvard Business School.
Follow Stuart Auerbach:
About Ampersand Capital Partners, Unilever: Ampersand is a middle market private equity firm focused on investments in two core sectors: Healthcare and Industrial.
Abbie Barbir
Senior Security Advisor of Aetna
Follow Abbie Barbir:
About : Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Rupinder Singh
Sr Application Software Delivery Advisor of Aetna
Follow Rupinder Singh:
About : Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Lien Suandy
Senior Application Software Delivery Advisor of Aetna
Senior Application Software Delivery Advisor at Aetna.
Follow Lien Suandy:
About : Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Lien Suandy
Senior Application Software Delivery Advisor of Aetna
Senior Application Software Delivery Advisor at Aetna.
Follow Lien Suandy:
About : Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Ronald Greeno
Board Advisor of Honor
Ronald Greeno, MD is the Chief Strategy Officer for IPC Healthcare, Inc. and was the Co-Founder of Cogent Healthcare Inc. where he served most recently as Executive Vice President of Strategy & Innovation. Prior to that, he was the Chief Medical Officer of Cogent Healthcare Inc. for 17 years, responsible for developing and managing Cogent’s national network of hospitalist physicians and for the development of the medical management approach. Considered a pioneer in Hospital Medicine, Ronald Greeno is a nationally recognized expert on hospitalist programs and their clinical and administrative management.
Follow Ronald Greeno:
About : Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.
Patricia Geraghty
Editorial Advisory Board Member of Sharecare
Patricia Geraghty, Sharecare Editorial Advisory Board Member, is a Nurse Practitioner with a passion for women’s health. She loves translating complicated cutting edge health information into practical and achievable plans that make women’s lives better. Ms. Geraghty did her graduate work on exercise and working mothers. She was the coordinator of an innovative Nurse Practitioner program in Oakland, California, before returning to her first love, patient care. She now practices in northern California and teaches women’s health content in local graduate nursing education programs. She speaks nationally on topics pertinent to women’s health across the lifespan. She has authored articles for professional journals. She lives in northern California with her husband and has two grown sons. Affiliations: • Holy Names University, Oakland, California Education • Post Master’s Special Studies Family Nurse Practitioner • Masters in Nursing Women’s Health Nurse Practitioner, University of California, San Francisco • BS, Biological and Behavioral Development, University of California, Davis Certifications • Women’s Health Nurse Practitioner, National Certification Corporation • Family Nurse Practitioner, American Nurse’s Credentialing Center
Follow Patricia Geraghty:
About : Sharecare is a health and wellness engagement platform providing consumers with information, programs and resources to improve their health.
Charles Sawyers
Member of the Scientific Advisory Board of Blueprint Medicines
Charles Sawyers has been a member of the Board of Directors since 2013. He qualifies as an independent Non-Executive Director. He is a member of the Research & Development Committee and the Governance, Nomination and Corporate Responsibilities Committee. In the United States Sawyers is chair of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center, professor of medicine and of cell and developmental biology at the Weill Cornell Graduate School of Medical Sciences, and an investigator at the Howard Hughes Medical Institute. He serves on US President Barack Obama’s National Cancer Advisory Board and is past president of the American Association of Cancer Research and former president of the American Society for Clinical Investigation. He also is a member of the US National Academy of Sciences and Institute of Medicine. Sawyers received his M.D. from the Johns Hopkins School of Medicine in the United States, and worked at the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, for nearly 18 years before joining Memorial SloanKettering in 2006. An internationally acclaimed cancer researcher, he co-developed the Novartis cancer drug Gleevec/Glivec, and has received numerous honors and awards, including the LaskerDeBakey Clinical Medical Research Award in 2009. Sawyers is a member of the Scientific Advisory Board of Agios Pharmaceuticals, Inc. in the United States.
Follow Charles Sawyers:
About ORIC Pharmaceuticals, The Howard Hughes Medical Institute, Weill Cornell Graduate School of Medical Sciences: Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
William Hahn
Member of the Scientific Advisory Board of Blueprint Medicines
William Hahn is a Chief Operating Officer at the Dana-Farber Cancer Institute. Also at Dana-Faber, he co-directs the Center for Cancer Genome Discovery and serves as the Chief of the Division of Molecular and Cellular Oncology as well as Chair of the Executive Committee for Research. He is an Institute Member of the Broad Institute of MIT and Harvard. Hahn has made numerous seminal discoveries that have informed our current molecular understanding of cancer and which have defined new conceptual paradigms and formed the foundation of new translational studies.
Follow William Hahn:
About Broad Institute, Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Solasta Ventures: Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Francesco Izzo
Surgeon Advisory Board of Domain Surgical
Dr. Francesco Izzo received his medical degree from the University of Naples, Federico II Medical School, Italy. He completed a general surgery residency at the University of Naples, Italy and then completed a fellowship in Surgical Oncology at the University of Texas Anderson Cancer Center. Dr. Izzo has been on the faculty in the Department of Surgical Oncology at the National Cancer Institute of Naples, Italy since completing his fellowship. He is now Full Professor of Surgery, Director and Coordinator of the Abdominal and Hepatobiliary Surgical Oncology Division and Chief of Liver Tumor Study Group at the National Cancer Institute of Naples, Italy. Dr. Izzo’s clinical practice and research focuses on surgical oncology new treatments particularly for patients with Hepatobiliary and pancreatic tumors. Dr. Izzo has been a pioneer in designing new treatments for patients with liver tumors, including radiofrequency ablation, improved techniques for surgical removal of liver cancers, and several types of direct tumor injection therapy. Dr Izzo is principal investigator on a number of National and International protocols for the basic science and clinical treatment on primary and metastatic hepatobiliary cancers Dr. Izzo is the author or co-author of over 220 publications, 18 book chapters, many dealing with the treatment of patients with hepatocellular cancer, gallbladder cancer, bile duct cancer, pancreatic cancer or metastases from a number of different tumor types.
Follow Francesco Izzo:
About : Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Robert Glasgow
Surgeon Advisory Board of Domain Surgical
Dr. Robert E. Glasgow is currently an Associate Professor (Clinician Scholar) at the University of Utah School of Medicine, Director of Minimally Invasive Surgery and Section Chief of Gastrointestinal and General Surgery for the Division of General Surgery, and Vice Chairman of Clinical Operations and Quality for the Department of Surgery at the University of Utah. After graduating with a Bachelor of Science from Stanford University and Doctor of Medicine from the University of California, San Francisco, Dr. Glasgow completed a General Surgery Residency and Research Fellowship in Gastrointestinal Surgery at the University of California, San Francisco then a Fellowship in Advanced Minimally Invasive and Gastrointestinal Surgery at Legacy Health System in Portland, Oregon. Dr. Glasgow’s clinical and research focus is in the area of gastrointestinal surgery with a special emphasis on minimally invasive techniques in the management of gastroesophageal and hepatopancreatobiliary disorders. Dr. Glasgow specializes in the treatment of benign and malignant disorders of the esophagus, stomach, intestines, liver, gallbladder, pancreas and biliary tree. He is also an expert in the minimally invasive treatment of hernia disease, including abdominal wall and groin hernias as well as hiatal hernias. As his research and administrative interests are in the area of optimization of surgical quality and outcomes, Dr. Glasgow directs the Department of Surgery participation in the American College of Surgeons’ National Surgical Quality Improvement Program. In this role, he helps to oversee quality improvment projects within the Department of Surgery with the goal of maintaining the University of Utah at the highest level of surgical care in the country.
Follow Robert Glasgow:
About University of Utah School of Medicine: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Timothy Kriewall
Corporate Advisory Board of Domain Surgical
Dr. Kriewall is presently a Program Director at the Kern Family Foundation, a non-profit organization committed to driving entrepreneurial education in engineering pedagogy at private universities across the United States. He is also President Emeritus of Wisconsin Lutheran College located in Milwaukee, Wisconsin. From 2000 to 2003, Dr. Kriewall was Vice President of Research and Development at Medtronic Xomed, where his teams developed surgical tools for ear-nose-throat (ENT) surgery. Earlier in his career he was Director of Research and Development at Medtronic Perfusion Systems, and Technical Manager at 3M Cardiovascular Systems, where he was responsible for the development of cardiopulmonary bypass systems. While at 3M, he was the technical lead for the first-ever cochlear implant to receive FDA approval in 1984. Dr. Kriewall holds Bachelor’s and Master’s degrees in electrical and computer engineering from the University of Michigan and Stanford University, respectively, and a Ph.D. in biomedical engineering from the University of Michigan where he served on their faculty for eight years before entering industry in 1981. He left Michigan as an Associate Professor of Obstetrics and Gynecology where he conducted research in the field of perinatal medicine. Dr. Kriewall is a Fellow of the American Institute of Engineering in Medicine and Biology. He has authored 19 publications in scientific journals, presented at numerous national and international meetings, written chapters in medical text books, and he is a co-inventor named on five patents.
Follow Timothy Kriewall:
About : Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Frank Shannon
Corporate Advisory Board of Domain Surgical
Dr. Shannon is a cardiovascular surgeon with William Beaumont Hospital in Royal Oak, Michigan. Dr. Shannon has authored numerous publications in cardiovascular and general surgery, and is a reviewer for the Annals of Thoracic Surgery. Dr. Shannon is a well-known surgical valve design innovator, with particular expertise in mitral and tricuspid valve systems, percutaneous/minimally accessible mitral annular remodeling devices, aortic valves, and minimally invasive devices used in atrial ablation procedures. Dr. Shannon sits on the scientific advisory board of Micardia, a BioStar Ventures portfolio company, and is a consultant to Medtronic, Datascope, and Pequot Capital Management.
Follow Frank Shannon:
About Datascope Corp, Medtronic, William Beaumont Hospital: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Jim Krieg
Corporate Advisory Board of Domain Surgical
Dr. Krieg is an Associate Professor of Orthopaedic Surgery at the University of Washington and Harborview Medical Center in Seattle, Washington. He is a board certified surgeon whose practice focuses on orthopedic trauma, including care of complex fractures and management of multiply injured patients. An active researcher and educator, he teaches nationally and internationally. He currently serves on the North American Musculoskeletal Trauma Education Committee of the Arbeitsgemeinshaft fur Osteosyntesefragen (AO). As an innovator, he has seen two of his ideas for medical devices successfully developed and brought to market. He is a frequent industry collaborator and invited speaker.
Follow Jim Krieg:
About University of Washington: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Frank Shannon
Corporate Advisory Board of Domain Surgical
Dr. Shannon is a cardiovascular surgeon with William Beaumont Hospital in Royal Oak, Michigan. Dr. Shannon has authored numerous publications in cardiovascular and general surgery, and is a reviewer for the Annals of Thoracic Surgery. Dr. Shannon is a well-known surgical valve design innovator, with particular expertise in mitral and tricuspid valve systems, percutaneous/minimally accessible mitral annular remodeling devices, aortic valves, and minimally invasive devices used in atrial ablation procedures. Dr. Shannon sits on the scientific advisory board of Micardia, a BioStar Ventures portfolio company, and is a consultant to Medtronic, Datascope, and Pequot Capital Management.
Follow Frank Shannon:
About Datascope Corp, Medtronic, William Beaumont Hospital: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Jim Krieg
Corporate Advisory Board of Domain Surgical
Dr. Krieg is an Associate Professor of Orthopaedic Surgery at the University of Washington and Harborview Medical Center in Seattle, Washington. He is a board certified surgeon whose practice focuses on orthopedic trauma, including care of complex fractures and management of multiply injured patients. An active researcher and educator, he teaches nationally and internationally. He currently serves on the North American Musculoskeletal Trauma Education Committee of the Arbeitsgemeinshaft fur Osteosyntesefragen (AO). As an innovator, he has seen two of his ideas for medical devices successfully developed and brought to market. He is a frequent industry collaborator and invited speaker.
Follow Jim Krieg:
About University of Washington: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
David Thomas
Corporate Advisory Board of Domain Surgical
Dr. Thomas is a practicing plastic surgeon in Salt Lake City, Utah. He attended the University of Utah for undergraduate and medical school, graduating in 1974. He completed his residency training in general surgery and plastic surgery at UCLA Medical Center, and completed an additional fellowship in craniofacial surgery under the tutelage of Dr. Henry Kawamoto, one of the world’s leading experts in this field, at UCLA. From 1990 to 1993, in addition to maintaining his private practice, he became a full time member of the faculty of the University of Utah School of Medicine as Associate Professor of Surgery in Plastic Surgery. Dr. Thomas has served on the Board of Directors of Interplast, Inc., a non-profit organization providing reconstructive surgery to patients in underdeveloped countries, and has volunteered services on several trips to South and Central America, Asia, and Africa.He is the past President of the Utah State Plastic Surgery Society and past Chairman of the Division of Plastic Surgery at LDS Hospital and Primary Children’s Medical Center. Dr. Thomas is Board Certified by the American Board of Plastic Surgery, and is a member of the American Society of Plastic Surgeons, American Society for Aesthetic Plastic Surgery, American Society of Maxillofacial Surgery, Utah State Plastic Surgery Society, Salt Lake Surgical Society, and he is a Fellow of the American College of Surgeons.
Follow David Thomas:
About : Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Francis Wapner
Corporate Advisory Board of Domain Surgical
Dr. Wapner is a practicing ophthalmologist in Salt Lake City, Utah. He completed his undergraduate studies at the University of Pennsylvania where he graduated Magna Cum Laude. He continued his studies at Columbia University where he received his doctorate in medicine. Dr. Wapner served his internship at the University of Utah/LDS Hospital in Salt Lake City. Following his internship he went on to become Chief Resident at the Edward S. Harkness Eye Institute at Columbia University.Dr. Wapner serves as a clinical instructor in Ophthalmology at the University of Utah. He is the Medical Director at the Physicians Surgery Center, as well as the Chairman of the Department of Ophthalmology at St. Marks Hospital. Dr. Wapner is board certified by the American Academy of Ophthalmology. He is a Fellow of the American College of Surgeons, as well as a member of the American Academy of Ophthalmology, American Board of Ophthalmology, and American Society of Cataract and Refractive Surgeons.
Follow Francis Wapner:
About Physicians Surgery Center, University of Utah: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Jonathan Lord
Advisor of Third Rock Ventures
Jonathan Lord currently serves as the Chair of the Board of Directors of Dexcom, as a Director at Stericycle, and serves on advisory boards for Serco PLC (UK), Anthelio Health and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School. A nationally recognized leader in innovations in health care, Lord became the University of Miami’s Chief Innovation Officer when he returned to his alma mater after three decades in healthcare leadership roles, in September 2011. In March 2012, Lord was named Chief Operating Officer of the Miller School of Medicine and UHealth-University of Miami Health System. He completed a financial turnaround of the Miller School. A board-certified forensic pathologist who began his medical career in the U.S. Navy and later served as Chief Operating Officer of the American Hospital Association and several biotech companies, Lord served as the CEO for Navigenics, Inc. following his tenure as the former Chief Innovation Officer and Senior Vice President of Humana. During his time at Humana, he created Humana’s Innovation Center, which combines research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Further cementing his ties to UM, he oversaw the creation of the UM/Humana Health Resources Center on the Miller School campus in 2006. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention’s Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the Joint Commission on Accreditation of Health Care Organizations. He was a member of the President’s Council at UM, an advisory group of some of the University’s most prominent alumni. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine.
Follow Jonathan Lord:
About : Third Rock Ventures invests in transformational life science companies that show high growth potential
Dennis Purcell
Founder & Senior Advisor of Aisling Capital
Dennis Purcell has served as the Senior Managing Partner of Fund I and Fund II since February 2000 and is responsible for the management of the Partnership. Prior to joining Fund I, Dennis Purcell served as Managing Director of the Life Sciences Investment Banking Group at Chase H&Q (formerly Hambrecht & Quist, “H&Qâ€) for over five years, and served on the Executive Committee of Hambrecht & Quist. While at Hambrecht & Quist, he was directly involved with over two hundred completed transactions and supervised over $10 billion of financing and advisory assignments in the pharmaceutical, biotechnology, and medical products industries. During his tenure, BioWorld and other industry publications cited H&Q as the leading underwriter of life sciences securities. Dennis Purcell has also often been cited as one of the sector’s leaders. He was honored in the “Biotech Hall of Fame†by Genetic Engineering News and named to the Biotechnology All-Stars list by Forbes ASAP. Prior to joining H&Q, Dennis Purcell was a Managing Director in the Healthcare Group at PaineWebber, Inc. Dennis Purcell currently serves as a director of Dynova Laboratories, Inc. and Xanodyne Pharmaceuticals, Inc. Previously he served as a director of Aton Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc., Cengent Therapeutics, Inc., and Valentis, Inc. He is also a member of the Board of Directors of the Biotechnology Industry Organization (BIO) – Emerging Companies Section. He has served as a member of the Advisory Council at Harvard Medical School.
Follow Dennis Purcell:
About Aisling Capital, bioWorld, Hambrecht & Quist, PaineWebber, Poliwogg Holdings: Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by
Alex Turkeltaub
Co-Founder & Senior Advisor of Roam Analytics
Alex is the Co-Founder and Chief Executive of Roam. Before Roam, Alex co-founded and served as Chief Executive of Frontier Strategy Group (FSG), a venture-backed data and analytics company focused on emerging markets that currently serves more than 250 leading multinationals. Alex and his family immigrated to the United States from the Soviet Union in 1988. He holds B.A. and M.A. degrees in International Relations from Stanford University and a J.D. from the Yale Law School.
Follow Alex Turkeltaub:
About Roam Analytics: Roam transforms patient and physician pathway analysis through a proprietary artificial intelligence platform built for the healthcare.
Nimrit Gill
Member of the Clinical Advisory Board of Castlight Health
Gill graduated from the University of the Pacific School of Dentistry focusing in general dentistry. She is a member of the American Dental Association, the California Dental Association, and the Santa Clara County Dental Society. For the past several years, she has been working in private practices in San Mateo and Fremont, and provides care to both adult and pediatric patients. Her outside interests include traveling and community service.
Follow Nimrit Gill:
About : Castlight Health provides a healthcare navigation platform with resources for benefits, and vendors.
Siobhan Nolan Mangini
Advisor of Castlight Health
Siobhan is responsible for Castlight’s corporate planning, business operations, finance, and accounting functions. Prior to joining Castlight Siobhan worked at Bain & Company, specializing in the health care and private equity practices. Siobhan began her career at the Kaiser Family Foundation as an investor responsible for managing the foundation’s endowment. Siobhan has an MBA from Stanford Graduate School of Business, MPA from the Harvard Kennedy School of Government and a BS from the Wharton School at the University of Pennsylvania.
Follow Siobhan Nolan Mangini:
About : Castlight Health provides a healthcare navigation platform with resources for benefits, and vendors.
Laurie Jacobson
Member of the Clinical Advisory Board of Castlight Health
Jacobson is a dermatologist and Mohs surgeon who practices in Seattle, Washington. She received her medical training at the University of Illinois at Chicago and completed her residency at Case Western Reserve University. She then completed a fellowship in Mohs surgery and cutaneous oncology at the Laser & Skin Surgery Center of New York. Jacobson lectures nationally and has written textbook and journal articles on topics ranging from novel skin cancer treatments to cosmetic enhancement of scars. Her practice is focused on the prevention and treatment of skin cancer.
Follow Laurie Jacobson:
About : Castlight Health provides a healthcare navigation platform with resources for benefits, and vendors.
Member of the Clinical Advisory Board of Castlight Health
Ahluwalia graduated from The George Washington University School of Medicine and completed his anesthesiology residency at Stanford University Medical Center. He completed a Pain Management fellowship at Stanford, and then stayed on faculty for one year at Stanford. Prior to joining the VA Palo Alto. Dr. Ahluwalia currently practices both anesthesiology and pain management, and enjoys the diversity of private practice and academic practice at the VA. His outside interests include bicycling, surfing, snowboarding, and traveling.
Follow Navneet Ahluwalia:
About : Castlight Health provides a healthcare navigation platform with resources for benefits, and vendors.
Elizabeth Verner-Cole
Member of the Clinical Advisory Board of Castlight Health
Verner-Cole is an ophthalmologist specializing in vitreoretinal surgery in Portland, Oregon. She received her medical school training at the University of Texas-Houston Medical School. She completed her internship at The Methodist Hospital, Houston, Texas, and her ophthalmology residency at the University of Texas-Houston. Verner-Cole completed a year-long fellowship in Ophthalmic Pathology at The Methodist Hospital in Houston, Texas, followed by a two-year fellowship in vitreoretinal surgery at Casey Eye Institute in Portland, OR.
Follow Elizabeth Verner-Cole:
About : Castlight Health provides a healthcare navigation platform with resources for benefits, and vendors.
Jeff Wood
Member of the Clinical Advisory Board of Castlight Health
As a pediatric dentist, Wood brings a background in medical and dental education as well as clinical practice to Castlight Health. He holds a BS in Biology with a minor in Psychology from Virginia Commonwealth University. He completed both dental school and his postgraduate residency in pediatric dentistry at the Medical College of Virginia.
Follow Jeff Wood:
About : Castlight Health provides a healthcare navigation platform with resources for benefits, and vendors.
Lynn Salo
Advisor, Former VP of Facial Aesthetics Allergan Medical of TRUINJECT
Lynn Salo is a 25-year veteran of Allergan whose career has provided her with strong strategic and commercial experience across global healthcare pharmaceutical, biologic, and device markets in Canada, Europe, and the United States. Formerly the Vice President of Sales and Marketing for the Facial Aesthetic Division of Allergan Medical, Lynn led a growth strategy through strategic business development acquisitions. Prior to her current position, Lynn has held various business unit leadership positions throughout her years at Allergan. Highlights include leading the 250-person U.S. Neurosciences Division as Vice President of Sales and Marketing, overseeing BOTOX® therapeutic applications for patients with neurologic conditions resulting in movement disorders and upper limb spasticity, spearheading the creation and expansion of a new 226-person Urology business vertical as Vice President of Sales and Marketing – U.S. Urologics, developing the Glaucoma Ophthalmic commercial strategy for Europe, Middle East, and Africa as Strategic Marketing Director EMEA, and leading Allergan’s commercial UK/Eire organization as Business Unit Head of Allergan Ophthalmics. Lynn has launched several important products for Allergan including BOTOX®, Vectra®XT, ALPHAGAN®, LUMIGAN®, SANCTURA XR®, and numerous dry eye products. Lynn sits on the Boards of the Medical Device Manufacturer’s Association, Girls Inc. Orange County, and is a member of Orange County United Way Women’s Philanthropy Society. Lynn was recently nominated for an Orange County Business Journal ‘Women in Business’ Award, and is now the recipient of Girls Inc. Member of the Year Award for her philanthropic contributions. She holds an Honors Bachelor of Science degree in Microbiology from the University of Toronto, and a Master of Business Administration from the University of Southern California.
Follow Lynn Salo:
About : TRUINJECT™ is a software company focused on the innovation, development & commercialization of medical products for the injectable market.
Steve Carlson
Advisor, Former CEO Obagi Medical of TRUINJECT
Follow Steve Carlson:
About : TRUINJECT™ is a software company focused on the innovation, development & commercialization of medical products for the injectable market.
Ryne Natzke
Advisor of HealthX Ventures
Follow Ryne Natzke:
About : Madison, WI based venture fund focusing on seed stage investments in digital health companies
Stephen Burley
Scientific Advisor of Proteorex Therapeutics Inc.
Follow Stephen Burley:
About : Expanding horizons to find cures
Monte Stettin
Advisor of doc.ai
Follow Monte Stettin:
About : doc.ai is a digital health company designed for a new generation of medical research.
Raymond Raven
Medical Advisor of AppliedVR
Follow Raymond Raven:
About : AppliedVR offers virtual reality-based therapeutic treatments that address the complexity of chronic pain.
Ankit Mahadevia
Advisor of Atlas Venture
Ankit Mahadevia is a principal in the life sciences group and focuses on novel drug discovery platforms, therapeutic products, and other medical technologies that meet a significant unmet clinical need. Prior to joining Atlas in 2008, Ankit worked on product and business development with the founding team at Arcion Therapeutics. He has also held positions in business development both at Genentech and at Vanda Pharmaceuticals. Previously, he worked in the health care groups of McKinsey & Company and Monitor Group. Ankit began his career in health care policy, with roles in the U.S. Senate Health, Education, Labor, and Pensions committees, the U.S. Government Accountability Office, and the Mexican Institute of Social Security (IMSS). Ankit currently serves on the boards of Atlas companies Annovation Biopharma, RaNA Therapeutics, Lumavita, and Fibrex Medical. He also works closely with Arteaus Therapeutics, JenaValve, and Nimbus Discovery and previously worked with Sirion Therapeutics (acquired by Alcon and Bausch & Lomb). Ankit is also actively involved in the Shire/Atlas Venture Alliance and the Atlas/Monsanto Seed Fund Alliance.
Follow Ankit Mahadevia:
About Annovation BioPharma, Rodin Therapeutics, Spero Therapeutics: Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Samantha Truex
Advisor of Atlas Venture
Sam is chief business officer of Padlock Therapeutics. She has 20 years of experience in the biotech industry. At Biogen Idec, Sam served as vice president in the corporate development group, and also served as program lead for multiple preclinical and launch-stage products. Prior to Biogen Idec, Sam led licensing and M&A transactions across multiple business units of Genzyme.
Follow Samantha Truex:
About Atlas Venture: Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Adam Rosenberg
Advisor of Atlas Venture
Adam is president and CEO of Rodin Therapeutics, where he also serves as a member of the Board of Directors. Adam has co-founded numerous companies, including Teleos Therapeutics, where he is CEO and director, as well as Link Medicine and Clean Membranes. He has also served in interim executive and strategic advisory roles with numerous healthcare and technology companies, including Brightstar (acquired by SoftBank) and Gecko Health Innovations (acquired by Teva Pharmaceuticals). Previously Adam co-founded Faber Law Group, a boutique business law firm focused on the biotechnology sector, and was a principal with Ovation Capital Partners, an early-stage technology venture fund.
Follow Adam Rosenberg:
About : Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Jeff Hatfield
Advisor of Atlas Venture
Jeff is president and chief executive officer of Vitae Pharmaceuticals. Prior to joining Vitae Pharmaceuticals, Jeff worked at Bristol-Myers Squibb in a variety of executive positions, including: senior vice president of BMS’s virology and immunology divisions, where he was responsible for all aspects of the $1 billion business; president and general manager, Canada; and vice president, U.S. managed health care. While at BMS, Jeff was directly associated with several product successes, including Pravachol®, Plavix®, Avapro®, Abilify®, Reyataz®, and Atripla®.
Follow Jeff Hatfield:
About : Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Vivian J. Weinblatt, MS, CGC
Scientific Advisory Board Member of FDNA
Ms. Vivian Weinblatt is a certified genetic counselor with over 20 years of clinical experience in multiple settings. She has published book chapters on the topics of genetic counseling and multiple gestations. Ms. Weinblatt previously served as the president of the National Society of Genetic Counselors and the Genetic Counseling Foundation and is currently an adjunct professor at Arcadia University’s Genetic Counseling Program. Ms. Weinblatt obtained her undergraduate degree from Cornell University in Human Development and Family Studies, and her Master’s degree in Genetic Counseling from the University of California, Berkeley. Ms. Weinblatt is certified by the American Board of Medical Genetics, and is a Charter member of the American Board of Genetic Counseling.
Follow Vivian J. Weinblatt, MS, CGC:
About : FDNA develops facial dysmorphology novel analysis technology solutions for healthcare professionals.
Dr. Cynthia J.R. Curry, MD
Scientific Advisory Board & Steering Committee Member of FDNA
Dr. Curry is Professor of Pediatrics at the University of California, San Francisco and the Medical Director of Genetic Medicine Central California in Fresno, California and on the adjunct clinical faculty at Stanford. She is board certified in Pediatrics and Clinical Genetics and has been practicing clinical genetics in Fresno for over 30 years. Dr. Curry has pursued research studies on thrombophilia, syndrome delineation in the fetus and newborn, and causes of intellectual disability and birth defects. She has held many national positions in both genetics and pediatrics and speaks nationally and internationally.
Follow Dr. Cynthia J.R. Curry, MD:
About : FDNA develops facial dysmorphology novel analysis technology solutions for healthcare professionals.
Damon Campolo
Strategic Advisor of CareAcademy
Damon brings a successful track record spanning 20 years of business development and sales experience across a variety of industries; technology, Internet & Media, eCommerce and Financial Services. Damon has held senior revenue generating roles at Arc Worldwide, EarthLink, Visa USA, and most recently Art.com – where he founded their Business Development department, hired and trained a team of 10 and grew revenues over $4MM in just 2 years. Damon is responsible for new client acquisition and revenue growth at NextUser.
Follow Damon Campolo:
About LicenseSpring, Pathstream: Online training empowering senior care professionals to deliver the highest caliber of service and improve the lives of older adults.
Lee Hartwell
Scientific Advisors of Arrowhead Pharmaceuticals
Dr. Hartwell is a well-known expert in cancer biology and was awarded the Nobel Prize in Medicine in 2001 for his ground-breaking work in cell cycle regulation.Dr. Hartwell is President of the Fred Hutchinson Cancer Research Center in Seattle, Washington. His insights into cell cycle control are being used at the Hutchinson Center and elsewhere to develop treatments for cancer and other diseases. Dr. Hartwell is involved in national and international projects to increase the number of laboratories working in protein diagnostics, develop more team science, improve the availability of informatics for data sharing, provide standardized reagents and stimulate new technology development. Dr. Hartwell is the recipient of many national and international scientific awards. His honors include the Albert Lasker Basic Medical Research Award, the Gairdner Foundation International Award and the Alfred P. Sloan Award in cancer research. He is a member of the National Academy of Sciences. He earned his B.S. at the California Institute of Technology and his Ph.D. from the Massachusetts Institute of Technology. He joined the University of Washington faculty in 1968 and has been a genetics professor there since 1973. In 1996, he joined the faculty of Seattle’s Fred Hutchinson Cancer Research Center and, in 1997, became its president and director.
Follow Lee Hartwell:
About : Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Joseph Vacanti
Scientific Advisory Board Member of Ocata Therapeutics
John Homans Professor of Surgery and Director of the Laboratory for Tissue Engineering and Organ Fabrication at Harvard Medical School and the Massachusetts General Hospital. Dr. Vacanti is a member of Institute of Medicine of the National Academies, and has received numerous awards and honors, including the Thomas G. Sheen Award and the James Bartlett Brown Award from the Society of Plastic and Reconstructive Surgery, and the Clemson Award from the Society for Biomaterials.
Follow Joseph Vacanti:
About : Ocata Therapeutics, Inc. is a clinical stage biotechnology company
Murari Sikaria
Advisor of Moneta Ventures
Follow Murari Sikaria:
About : Moneta Ventures is a venture capital firm that invests in early-stage technology and healthcare businesses.
Joe Geiger
Advisors of HeadRehab
Joe Geiger is a Advisor at HeadRehab.
Follow Joe Geiger:
About First Nonprofit Foundation: HeadRehab develops virtual reality systems with a focus on neurocognitive performance and enhancement tools.
Mark Osoteo
Sr. Advisor of CoverMyMeds
Sr. Advisor at CoverMyMeds.
Follow Mark Osoteo:
About : CoverMyMeds is a healthcare tech platform helping doctors and pharmacists complete PA and insurance coverage determination forms for drugs.
Christopher K. Zarins
Founder & Senior Advisor for Clinical Affairs of HeartFlow
Follow Christopher K. Zarins:
About HeartFlow: HeartFlow is a medical technology company that provides new methods of diagnosis and treatment of cardiovascular disease.
Renee Dua
Founder and Advisor of Heal
Dr. Dua is board certified in nephrology, hypertension, and internal medicine and served as Chief of Medicine at Valley Presbyterian and Simi Valley Hospitals. She is now the Founder and Advisor of Heal. She completed her BS in Biochemistry at UC San Diego, her MD at Rosalind Franklin University, her residency at UCLA, and her fellowship in nephrology at USC. Renee and her husband are enjoying the travails of being parents to a rambunctious 1-year-old boy.
Follow Renee Dua:
About Burrito Labs, Heal: Heal is an in-home primary care practice that offers modern doctor house calls, one-touch telemedicine and remote monitoring for seniors.
John Carnes
Executive Advisor, Information Security of Anthem
John Carnes has worked more than 20 years in IT, as both a consultant and information security professional. He holds his CISSP, ISSAP specialization and HCISPP. John has acted as the subject matter expert for a Fortune 50 company’s identity management, authentication and authorization architect, and has worked as an infosec first responder.
Follow John Carnes:
About : Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler.
Joan Vernikos
Advisor of StandDesk
Author of Book: Sitting Kills, Moving Heals, How Everyday Movement Will Prevent Pain, Illness, and Early Death. Vernikos taught medical students at Ohio State University before being recruited by NASA in 1964. Former Director of NASA’s Life Sciences (1993-2000), Vernikos is a recognized leader in the field of stress management and coping.
Follow Joan Vernikos:
About : A Wellness Company That Makes Awesome Standing Desks
Adam Rizvi, MD
Founding Advisor of Biovirtua
Adam Rizvi is the Neurocritical Care Director at Carondelet.
Follow Adam Rizvi, MD:
About Biomarker Labs, Biovirtua, Carondelet Health Network, Sound Physicians: Biovirtua offers a platform that monitors changes to human movement.
Jeanne McCann
Executive Technology Advisor of Nuance Communications
Jeanne is the senior Nuance executive for Nuance’s IBM relationships and also works on matters of R&D strategy, prioritization, and operational excellence. Jeanne has been with Nuance for 10 years. Prior to joining Nuance, Jeanne led development programs at Lernout & Hauspie and before that Dragon Systems and Wang. Jeanne has over 30 years of experience in technology development leadership, and holds a B.A. from Simmons College and an M.B.A. from Babson College.
Follow Jeanne McCann:
About Nuance Communications: Nuance Communications provides conversational AI innovations that bring intelligence to everyday work and life.
Kathleen Lester
Advisory Board Member of Medal
Follow Kathleen Lester:
About : Extract, transport, translate, and share medical records faster.
Joseph Kim
Sr. Advisor, Digital Health Office, Translational Technology & Innovation of Eli Lilly
Follow Joseph Kim:
About Eli Lilly, Eli Lilly: Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Kyla Driscoll
Senior Research Advisor of Eli Lilly
Kyla Driscoll is currently a Senior Research Advisor and Group Leader in the Oncology Research division at Eli Lilly. Kyla Driscoll joined Eli Lilly In 2008 and is based in the New York laboratories of Lilly where her current efforts are focused on immune oncology targets and combinations with mechanistic analysis of biological activity. Driscoll is responsible for oversight and development of Lilly’s TGFβ platform, various immune checkpoint antagonists, and myeloid immuno-biology. These programs include both small molecules and biologics, and have advanced to various phases of clinical development. Driscoll obtained her Ph.D. in 2007 in microbiology and immunology where she studied viral mechanisms of oncogenesis. Driscoll further completed postdoctoral training in cancer vaccine development prior to joining Lilly.
Follow Kyla Driscoll:
About : Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Amy Meadows
Senior Advisor, Consumer Marketing of Eli Lilly
Amy Meadows, head of consumer marketing for Lilly USA’s oncology business, has spent nearly two decades cultivating the art and science of marketing as an agency creative, an entrepreneur and, now, a client, most recently in healthcare. Recognised as a “gladiator for change” and one of Lilly’s Top 100 Innovators, Amy finds spirited purpose in empowering the voices of people who need to be heard – from those living with Alzheimer’s disease to those suffering from advanced/Stage IV cancer. She maximises her creativity outside of work through being an avid writer, artist, would-be Muppeteer and wrangler of five “tweenage” boys.
Follow Amy Meadows:
About : Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
David Kahn
Associate Engineering Advisor of Eli Lilly
Follow David Kahn:
About : Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Rafael Grossmann
Advisor of HealthCode.io
Follow Rafael Grossmann:
About : Collaborate Faster & Further! Discover and chat with innovators, clinicians and investors globally. Available on iOS and Android.
Rafael Grossmann
Advisor of HealthCode.io
Follow Rafael Grossmann:
About : Collaborate Faster & Further! Discover and chat with innovators, clinicians and investors globally. Available on iOS and Android.
Michael Flanagan
Advisor, Radiation Technical of Sterigenics
Michael Flanagan is a Radiation Technical Advisor at Sterigenics.
Follow Michael Flanagan:
About Sterigenics: Sterigenics is a provider of solutions in sterilization and ionization supply chain management; Providing sterilization services.
Theo Hanson
Advisory Board of One Great Gut
Follow Theo Hanson:
About : Curating & creating the best resources available for optimal gut health to empower your highest potential.
Dr. Duc Le MD
Medical Advisor – Functional Medicine and Neuro Linguistic Programming of One Great Gut
Follow Dr. Duc Le MD:
About : Curating & creating the best resources available for optimal gut health to empower your highest potential.
Dr. Christine Tara Peterson PhD, AHP, RYT
Scientific Advisory Committee: Immunology, Microbiology,Gut Microbiome, Ayurvedic interventions of One Great Gut
Follow Dr. Christine Tara Peterson PhD, AHP, RYT:
About : Curating & creating the best resources available for optimal gut health to empower your highest potential.
Michele Rooney MS PT RYT
Medical Advisor – pediatric physical therapist specializes in early Intervention&autism spectrum of One Great Gut
Follow Michele Rooney MS PT RYT:
About : Curating & creating the best resources available for optimal gut health to empower your highest potential.
Michele Rooney MS PT RYT
Medical Advisor – pediatric physical therapist specializes in early Intervention&autism spectrum of One Great Gut
Follow Michele Rooney MS PT RYT:
About : Curating & creating the best resources available for optimal gut health to empower your highest potential.
Willard Dere
Scientific Advisors of Hangzhou Just Biotherapeutics (Just China)
Professor of Medicine, Executive Director of Personalized Health, Co-Director, Center for Clinical and Translational Science at the University of Utah. Board Member of BioMalin Pharmaceutical, Ocera Therapeutics and Radius Health. Former VP of Eli Lilly. As SVP of Global Development at Amgen, he was responsible for the clinical development of Raloxifene and other drugs for cancer, inflammation and kidney diseases.MD, University of California, Davis.
Follow Willard Dere:
About : Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Robert Berliner
Member of the Board of Advisors of VG Life Sciences
Robert Berliner is the Of Counsel at Brooks Kushman P.C.
Follow Robert Berliner:
About Berliner & Associates, Brooks Kushman, Southern California Biomedical Council: VG Life Sciences discovers and develops drug therapies for cancers, infectious diseases, inflammatory diseases, and autoimmune disorders.
Russ Hensel
Member of the Board of Animal Toxicity Study Advisors of VG Life Sciences
Russ Hensel provides over 30 years of experience with Rhone-Poulenc Rorer, Covance Laboratories, Johnson & Johnson, and Tandem Labs. He designs and assesses pharmacokinetic data produced by our third party animal toxicity group. He received his PhD in Analytical Chemistry from Drexel University.
Follow Russ Hensel:
About : VG Life Sciences discovers and develops drug therapies for cancers, infectious diseases, inflammatory diseases, and autoimmune disorders.
Marshall Phelps
Member of the Board of Advisors of VG Life Sciences
Marshalll Phelps was appointed to Inventergy, Inc.’s Board of Directors on May 17, 2013. Phelps is a leading figure in the field of intellectual property management and performance, pioneering many of its leading strategies, generating unprecedented results and heading IP business and related activities at IBM and Microsoft. As CEO and Board Member of Article One Partners, he is actively engaged in helping businesses and governments improve patent quality and improve the Patent System. Phelps served as Corporate Vice President at IBM in the 1990s, responsible for overseeing standards, telecommunications policy, industry relations, licensing, intellectual property law and management of a worldwide intellectual property portfolio of more than 35,000 patents and 8,500 trademarks. By actively licensing these and other IP rights, such as trade secrets and copyrights, he transformed a function that had previously been costly overhead to a $2 Billion annual profit center. Prior to heading IP business, he served IBM as Director of Government Relations in Washington and as Vice President of Asia Pacific operations in Tokyo. From 2002-2010 Phelps served as Corporate Vice President and Deputy General Counsel for Intellectual Property and Licensing, Microsoft Corporation. At Microsoft, his duties entailed worldwide management of the company’s intellectual property portfolio, patent prosecution, licensing, standards and business development. He facilitated Microsoft’s emergence as one of the world’s largest IP companies with over 60,000 patents and applications, extensive copyright holdings and numerous trademarks. In 2006, Phelps was elected to the initial class of the Intellectual Property Hall of Fame. In 2001 he was founding partner with Nathan Myhrvold of Intellectual Ventures, now the largest acquirer of patents worldwide. His book, “Burning the Ships”, Intellectual Property and the Transformation of Microsoft, was published in 2009. Phelps has taught IP strategy at business, law or engineering schools at Duke, Cornell, UNC, and Berkeley and in Japan. He holds a B.A. and D.H.L from Muskingum University, an M.S. from Stanford Graduate School of Business, and a J.D. from Cornell University Law School.
Follow Marshall Phelps:
About : VG Life Sciences discovers and develops drug therapies for cancers, infectious diseases, inflammatory diseases, and autoimmune disorders.
Matthew Schiltz
Advisory Board Member and Investor of Parachute Health
Matthew Schiltz is the Advisory Board Member and Investor of Parachute Health.
Follow Matthew Schiltz:
About Parachute Health: Parachute Health is a provider of medical equipment ordering software.
Bob Zollars
Senior Advisor and Operating Partner of Frazier Healthcare Partners
Follow Bob Zollars:
About : Frazier Healthcare Partners is a healthcare investment firm for pharmaceuticals, healthcare services, & medical products.
Bob Lefton
Senior Advisor and Operating Partner of Frazier Healthcare Partners
Follow Bob Lefton:
About : Frazier Healthcare Partners is a healthcare investment firm for pharmaceuticals, healthcare services, & medical products.
Marc Savas
Advisor of Wendi
Follow Marc Savas:
About : Wendi is a digital app for healthcare that automates patient screening, insurance verification, scheduling, paperwork, and communications.
Jeff Morgan
Advisor of Wendi
Follow Jeff Morgan:
About : Wendi is a digital app for healthcare that automates patient screening, insurance verification, scheduling, paperwork, and communications.
Partha Mitra
Founder & Chief Scientific Advisor of Clarapath
Partha Mitra is the Professor at Cold Spring Harbor Laboratory.
Follow Partha Mitra:
About Clarapath, Cold Spring Harbor Laboratory, Indian Institute of Technology Madras: We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.
Reay Brown
Scientific Advisory Board of Ivantis
Dr. Reay H. Brown is a board certified ophthalmologist specializing in glaucoma, glaucoma surgery, and cataract surgery with intraocular lens implantation. He has been in practice in Atlanta since 1988. Dr. Brown earned his undergraduate degree from Harvard College Cum Laude and completed medical school at the University of Michigan. His training in ophthalmology was at the Wilmer Eye Institute of Johns Hopkins University. He then completed a glaucoma fellowship at the Bascom Palmer Eye Institute and returned to Johns Hopkins as Chief Resident and a member of the Hopkins faculty. Dr. Brown was selected as the first Pamela Firman Professor of Ophthalmology at the Emory Eye Center. Mrs. Firman made the donation for the professorship in gratitude for Dr. Brown’s care of her eyes. He served as the Director of the Glaucoma Service at Emory for eleven years prior to entering private practice with Atlanta Ophthalmology Associates in 1999. Dr. Brown has published more than 80 peer-reviewed articles on glaucoma, cataract surgery, and other aspects of eye care and is often asked to lecture on glaucoma at national and international meetings. He has received the Honor Award and the Senior Achievement Award from the American Academy of Ophthalmology. Dr. Brown is one of only a few ophthalmologists in Georgia who have received this prestigious award. Dr. Brown has been awarded 15 patents for new instruments to improve glaucoma and cataract surgery and has other patents pending. He continues to work on novel and improved approaches to glaucoma and cataract surgery. Dr. Brown has been selected by his peers to be listed each year in Best Doctors in America and was featured in a separate peer survey in Atlanta Magazine as one of the best ophthalmologists in Atlanta. Numerous media outlets, both local and national, have called attention to Dr. Brown’s contributions to cutting edge treatments in eye surgery.
Follow Reay Brown:
About Sight Sciences: Ivantis is focused on developing an innovative treatment for glaucoma which includes eye drops, laser therapy, and surgery.
Rama Potturu
Co-Founder & Advisor of XpertDox
Experienced leader providing strategy and thought leadership as a Business Partner/Evangelist disrupting through innovation
Follow Rama Potturu:
About Pivot Innovation, Silicon Valley Bank, XpertDox: Platform for finding the Best doctors, Hospitals or Trial for diseases
Allan Geliebter
Clinical Advisor of Gelesis
Senior Attending Psychologist, St. Luke’s-Roosevelt Hospital; Pioneer in the gastric balloon field. Dr. Geliebter is Professor of Psychology at Touro College, Member of the New York Obesity Nutrition Research Center at St Luke’s-Roosevelt Hospital, as well as Senior Research Scientist in the Department of Psychiatry at Columbia University. Dr. Geliebter’s research interests include biological and psychological aspects of Binge Eating Disorder and the Night Eating Syndrome in overweight and obese individuals, brain imaging and binge eating, brain imaging pre and post obesity surgery, brain imaging and stress induced eating, genetics of obesity and neuroimaging, and environmental approaches for obesity intervention, including price discounts on healthy foods. He has a number of NIH grants to explore these topics. Dr. Geliebter received his Ph.D. from Columbia University.
Follow Allan Geliebter:
About : Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Lee M. Kaplan
Clinical Advisor of Gelesis
Dr. Lee Kaplan is the Director of the Obesity, Metabolism & Nutrition Institute, founding director of the Weight Center at the Massachusetts General Hospital, and Associate Professor of Medicine at Harvard Medical School. Dr. Kaplan’s clinical expertise is in the areas of obesity medicine, gastroenterology, and liver disease. He has a special interest in the causes and complications of obesity and the development of new and more effective preventive strategies and therapies for this problem. Dr. Kaplan serves as Chair of the Nutrition and Obesity Section of the AGA, Chair-elect of the Bariatric Surgery section of The Obesity Society, director of the Blackburn Obesity Course at Harvard Medical School, and Co-Chair of the Dartmouth Device Development Conference in Obesity and Metabolism. He is a member of the NIH Clinical Obesity Research Panel, was Chair of the recent FDA workshop on Device Development for Obesity and Metabolic Diseases, and is a member of the Obesity Medicine Certification Steering Committee. Dr. Kaplan graduated from Harvard University and received his M.D. and Ph.D. in molecular biology from the Albert Einstein College of Medicine. He completed an internship and residency in internal medicine and a fellowship in gastroenterology at Massachusetts General Hospital and Harvard Medical School, and a fellowship in genetics at Brigham and Women’s Hospital.
Follow Lee M. Kaplan:
About : Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Glenn Taylor
Member of the Board of Advisor of DAS Health
Glenn Taylor, is Group President, Key Accounts, where he is responsible for over half of the Fortune 50 company’s $50 billion in annual revenue.He formerly served as Senior Vice President, Account Management, and President of the Company’s UnitedHealth Group Division, among other positions. Glenn Taylor held previous positions as Executive Vice President for Rush Presbyterian St. Lukes Hospital in Chicago, and Group Vice President for Baxter Healthcare / American Hospital Supply.He has a BA in Economics and Mathematics from St. Olaf College and an MBA from Lake Forest Graduate School.
Follow Glenn Taylor:
About : DAS Health is a leading provider of Health IT and management solutions and a trusted consultant to many physician groups.
James Nahirny
Advisor of PatientPing
James Nahirny is a Managing Director and Founding Partner of Bain Capital Ventures. Prior to founding Bain Capital Ventures in 2000, James Nahirny was a Partner at McKinsey & Company. At McKinsey, he worked closely with the senior management and boards of his clients on a broad range of strategic and operations issues. He previously worked in the Mergers and Acquisitions Group of First Boston in both New York and Tokyo. In addition to his firm and portfolio company responsibilities, James Nahirny serves on several community and industry boards, including Children’s Hospital Boston Board of Overseers, New England Venture Capital Association, and Yale Entrepreneurial Society. James Nahirny received an MBA with High Distinction from Harvard Business School, where he was a Baker Scholar, and a BA magna cum laude from Yale University.
Follow James Nahirny:
About : PatientPing is a care coordination data and software company that focuses on senior care and patients with complex needs.
Dimitri Krainc
Scientific Founder, Chairman of the Scientific Advisory Board of Lysosomal Therapeutics
Dimitri is Aaron Montgomery Ward Professor of Neurology, Chairman of the Ruth and Ken Davee Department of Neurology at the Feinberg School of Medicine and Northwestern Memorial Hospital and Director of Center for Rare Neurological Diseases at Feinberg. Previously, he spent 20 years at Harvard Medical School completing his research training followed by a neurology residency and fellowship in movement disorders at Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital. He then served on the clinical and research faculty in the Department of Neurology at MGH and Harvard Medical School.
Follow Dimitri Krainc:
About Lysosomal Therapeutics: Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Jay Skyler
Scientific Advisors of MannKind
Jay Skyler currently serves as a Professor of Medicine, Pediatrics and Psychology in the Division of Endocrinology Diabetes & Metabolism at the Leonard M. Miller School of Medicine at the University of Miami, where he has also held a number of key leadership roles in the clinical and drug development setting. He has played a key global leadership role in advancing the science and treatments of diabetes over the last five decades, where his own research has also focused on improving the care of type 1 diabetes through meticulous glycemic control, psychosocial and behavioral support and immune intervention. From 1993 until 2015, he was Chairman of the National Institute of Health-sponsored Diabetes Prevention Trial – Type 1 (DPT-1) and its successor Type 1 Diabetes TrialNet, a nationwide network conducting clinical trials to interdict type 1 diabetes. Jay Skyler has also held many positions at the American Diabetes Association (ADA), including President and member of the Board of Directors. He was founding Editor-in-Chief of Diabetes Care (an ADA publication), founding Scientific Editor of the International Diabetes Monitor, and currently is Senior Editor of Diabetes Technology & Therapeutics. He has served on the Board of Directors for multiple private and public companies including MiniMed, Amylin, Dexcom, Inc. DXCM and Moerae Matrix, Jay Skyler has been author, editor, or co-editor of 21 books and has written nearly 500 articles. Jay Skyler is a graduate of Pennsylvania State University and Jefferson Medical College, and did his postgraduate training in internal medicine and in endocrinology & metabolism at Duke University Medical Center.
Follow Jay Skyler:
About : MannKind focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes.
Janice Ryan
Advisor, Fisheries Conservation of WWF Canada
Janice Ryan is a Fishery Advisor for WWF-Canada with over 13 years’ experience in various sectors of the Newfoundland and Labrador fishing industry. A native of the island, Janice has worked with fish harvesters to build their capacity to implement sustainable fishing practices and adopt a fisheries conservation ethic. Today, she continues that work with WWF to help the organization effect change on a larger scale. Janice’s work has taken her more than 200 nautical miles offshore, working on fishing vessels to observe snow crab, shrimp and groundfish commercial fishery operations. She’s also had an amazing experience working as an observer on a king crab boat in the Bering Sea.Her passion for fisheries conservation at the grassroots level is tied to her deep and personal connection to the ocean—as a natural wonder, but, more profoundly, as the source of a culture and livelihood that has surrounded her since childhood.
Follow Janice Ryan:
About : For half a century, WWF has worked to protect the future of nature. WWF is Canada’s largest international conservation organization
Mike McGreal
Advisory Board of Workit Health
Follow Mike McGreal:
About : Workit Health is a virtual clinic dedicated to medically-assisted treatment and online therapy for substance use disorder.
Luciano Marraffini
Founder & Advisor of Intellia Therapeutics
Luciano Marraffini is an Assistant Professor of Bacteriology at Rockefeller University. Luciano’s laboratory investigates the underlying molecular mechanisms of CRISPR immunity, and seeks to employ this natural pathway to develop new technologies. He is a 2012 Rita Allen Foundation Scholar and the recipient of a 2012 NIH Director’s New Innovator Award. Luciano received his PhD from the University of Chicago where he studied bacterial pathogenesis, and completed his postdoctoral fellowship at Northwestern University.
Follow Luciano Marraffini:
About Eligo Bioscience, Intellia Therapeutics, The Rockefeller University: Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Michael E. Lewis
Co-founder, Chief Scientific Advisor of Cara Therapeutics
Dr. Lewis, one of our founders, has had extensive experience in the biopharmaceutical industry, and prior to that, about five years of experience in opioid research at the National Institutes of Health and the University of Michigan. Previously, Dr. Lewis received training in psychobiology research at the National Institute of Mental Health and at Clark University, where he received a Ph.D. in psychology, and then received postdoctoral training in psychopharmacology and neuropharmacology at the University of Cambridge. After establishing and directing a molecular neuropharmacology laboratory at DuPont, Dr. Lewis co-founded Cephalon, Inc. (Nasdaq; CEPH), serving as Director of Pharmacology and Senior Director of Scientific Affairs. Dr. Lewis later co-founded and served as Chief Scientific Advisor to Adolor Corporation (Nasdaq; ADLR), and was subsequently invited by Dr. Chalmers to co-found Arena Pharmaceuticals (Nasdaq; ARNA), where he served as a pre-IPO Director and Chief Scientific Advisor. Dr. Lewis is an inventor or co-inventor on 15 issued U.S. patents and is an author or co-author of numerous scientific papers, including over 40 publications on opioids and opioid receptors.
Follow Michael E. Lewis:
About Cara Therapeutics: Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.
Brian Fargo
Advisor of K5 Ventures
Brian Fargo is Advisor at High School Sports Entertainment.
Follow Brian Fargo:
About : K5 Ventures is an American early-stage funding platform that hosts, mentors, accelerates, and invests in technology-driven businesses.
John Kaelin
Senior Advisor of Centene
John Kaelin has diverse executive level experience in the health care industry spanning government, academia, US based health insurers and recently health systems in the Middle East. In 2014, John moved to Abu Dhabi, the capital of the United Arab Emirates where he served as a special advisor to the government as it implements a mandatory health insurance program and a government regulated price system. When he returned to the U.S. in the spring of 2015, he joined Centene as a senior advisor for health financing and policy and is supporting its health plans on rate setting, risk adjustment and policy issues. Previous positions include SVP for health reform at UnitedHealth Group and Executive Director of the University of Maryland’s Hilltop Institute where he supported that state’s efforts to implement managed care for Medicaid and a risk adjusted payment system.
Follow John Kaelin:
About Centene: Centene provides healthcare solutions to families and individuals in order for them to get well, stay well, and be well.
Don Kasle
Advisor of Carepoynt
Don Kasle is the Tech Coast Angels’ Chairman Emeritus, the largest Angel Investment Network in the USA and Senior Consultant at TriTech, Small Business Development Center. Don, a retired bank CEO, is Managing Partner of Alldas Partners, a financial services consulting company. He has over 40 years’ experience in executive management and service on boards of directors, as well as commercial banking and capital formation. Mr. Kasle is also an active investor in and a coach for start-up companies through his membership in the Tech Coast Angels where he also serves on the Board of Governors as well as a member of the executive committee for the Orange County Network. During his career, Mr. Kasle has served on over 30 Boards of Directors in the public, private and not-for profit sectors, including 7 bank boards.
Follow Don Kasle:
About : Carepoynt is the first Rewardsware for Healthcare program, platform and network for patients, providers, employers, payers and partners
Anthony Kelani
Advisor of mvmtAi
Anthony Kelani is a technologist and businessman with over 13 year of experience in the tech industry as a software engineer, data scientist, startup CEO and CTO. His background includes expertise in executing projects in web & mobile apps, distributed computing, SaaS, real-time video and data science. Anthony launched his career with the premier defense contractor, Northrop Grumman, where we was honored for his work in designing and developing life-saving situational awareness software for the United States military. He then became Head of Engineering at one of the first venture studios in Los Angeles. In 2013, he founded ShowKit, which was a TechCrunch Disrupt finalist in 2014 and exited a year later. After ShowKit, Anthony served as Head of Microsoft for Startups Los Angeles, where he worked closely with startup founders and the leading accelerators and VCs in the L.A. ecosystem. He is on the advisory board of several L.A.-based startups and continues to mentor founders at the preeminent accelerator programs in the nation. Anthony has a unique synthesis of engineering, product and business experience, which enables him to effectively evaluate and mentor entire early stage startup teams. His skills and ability to identify great teams catalyze his acumen for advising and providing quality deal flow to investors. As Managing Partner of the Los Angeles office, Anthony will focus his efforts on working closely with Quake’s accelerator founders in the areas of engineering and operations, expanding Quake’s investor and partner network, and assisting with fundraising and strategy. Due to his astute technical background, he will also serve as the CIO of the fund by architecting Quake’s data platform. Anthony is a strong advocate for the inclusion of minorities and women in tech, and has met with lawmakers on Capitol Hill to spur support for diversity and entrepreneurial success.
Follow Anthony Kelani:
About mvmtAi: Machine Learning, Computer Vision, Robotics, IoT, Mobile App, Information Technology, Computer Software, Health, Wellness, Healthcare
Will Summerlin
Advisor of mvmtAi
Will Summerlin is the Investor at ARK Investment Management LLC.
Follow Will Summerlin:
About ARK Investment Management: Machine Learning, Computer Vision, Robotics, IoT, Mobile App, Information Technology, Computer Software, Health, Wellness, Healthcare
Steve Carlin
Advisor of mvmtAi
Steve Carlin is an executive leader and advisor to multiple global startups. Founding director of mvmtAi inc, founder/CEO of Kebek Ventures, and venture partner/executive in residence at TransLink Capital. He was most recently President and Chief Strategy Officer of SoftBank Robotics. In this role, he oversaw all commercial activities and led the growth of the Americas team. Carlin previously worked at Facebook where he held the role of Global Head of Strategy – Gaming. In this role, he drove the global strategic vision for the company’s Gaming Business. Prior to joining Facebook Carlin was the Senior Director of Marketing and Insights for Ubisoft, the third largest video game publisher in the world. In this role, he oversaw the marketing and insights function for the North American operations of Ubisoft. His responsibilities included short and long term shopper and retail marketing visions for Ubisoft’s games, shaping the sales team’s national market plans, and developing the in-store and online programs for the world’s largest retailers. Before joining Ubisoft in 2009, Carlin worked at Energizer Battery Company where he held multiple roles in Sales, Channel Marketing and Brand Marketing. There he was responsible for, among other things, the development of channel strategy for Energizer’s business in the Grocery and Mass & Electronic classes of trade. Additionally, he not only conducted strategic consulting work for key customers including business plan and sales strategy development, but he was also responsible for the category management teams for the channel’s customers. Before his tenure at Energizer, Carlin worked for Procter & Gamble in Customer Business Development and Brand Marketing where he was responsible for marketing, sales and strategic project work for Procter & Gamble’s beauty care business, including the $600MM Cosmetic division. Carlin is a graduate of Miami University in Oxford, Ohio, where he holds a BA in Geology, and of Goizueta Business School at Emory University in Atlanta, where he holds an MBA (with Honors) in Marketing and International Business. He has also studied at Cornell, HEC business school in Pars and the UIBE business school in Beijing.
Follow Steve Carlin:
About Kebek Ventures, Translink Capital: Machine Learning, Computer Vision, Robotics, IoT, Mobile App, Information Technology, Computer Software, Health, Wellness, Healthcare
Abe Malkin
Advisor of mvmtAi
Physician and entrepreneur with passion for building and growing companies in the health and wellness industry.
Follow Abe Malkin:
About mvmtAi: Machine Learning, Computer Vision, Robotics, IoT, Mobile App, Information Technology, Computer Software, Health, Wellness, Healthcare
